• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于泼尼松龙脉冲疗法和电神经肌肉刺激(FREMS疗法)对一名患有格雷夫斯病和甲状腺眼病患者的胫前黏液性水肿进行综合治疗]

[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].

作者信息

Perepelova M A, Zaitseva E L, Bessmertnaya E G, Grusha Ya O, Sviridenko N Yu, Galstyan G R

机构信息

Endocrinology Research Centre.

Research Institute of Eye Diseases.

出版信息

Probl Endokrinol (Mosk). 2023 Aug 30;69(4):32-37. doi: 10.14341/probl12888.

DOI:10.14341/probl12888
PMID:37694865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10520899/
Abstract

Graves' disease (GD) is one of the urgent problems of modern endocrinology, characterized by a high frequency, polysystemic damage to the body, a steadily progressive course, diagnostic difficulties, a high degree of disability and often resistance to therapy. The manifestations of the disease include: thyrotoxicosis syndrome with impaired lipid and carbohydrate metabolism, and activation of multiple organ pathology in the form of thyroid eye disease (TED), pretibial myxedema, cardiovascular insufficiency, acropathy, lesions of the nervous, osteoarticular system, and other lesions. The development of multiple organ pathology can have a different sequence, different time intervals and different degrees of severity. Any developments in the direction of clarifying the etiopathogenetic, clinical diagnostic and treatment-rehabilitation measures are of undoubted significance. We present a clinical case of GD, TED and pretibial myxedema, in which an integrated approach was tested in the tactics of treating pretibial myxedema (a combination of pulse therapy with prednisolone and FREMS-therapy), as a result of which positive results were obtained within a short time.

摘要

格雷夫斯病(GD)是现代内分泌学的紧迫问题之一,其特点是发病率高、对身体造成多系统损害、病程呈稳步进展、诊断困难、致残程度高且常常对治疗耐药。该疾病的表现包括:伴有脂质和碳水化合物代谢受损的甲状腺毒症综合征,以及以甲状腺眼病(TED)、胫前黏液性水肿、心血管功能不全、肢端病、神经和骨关节系统病变等形式出现的多器官病变激活。多器官病变的发展可以有不同的顺序、不同的时间间隔和不同的严重程度。在明确病因发病机制、临床诊断以及治疗康复措施方面的任何进展都具有无疑的重要意义。我们展示了一例GD、TED和胫前黏液性水肿的临床病例,其中在胫前黏液性水肿的治疗策略中测试了一种综合方法(泼尼松龙脉冲疗法与FREMS疗法相结合),结果在短时间内获得了积极效果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/83b2c8b61463/problendo-69-12888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/572a0176efc4/problendo-69-12888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/240b8155ff94/problendo-69-12888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/aa3c5e229e48/problendo-69-12888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/83b2c8b61463/problendo-69-12888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/572a0176efc4/problendo-69-12888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/240b8155ff94/problendo-69-12888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/aa3c5e229e48/problendo-69-12888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1182/10520899/83b2c8b61463/problendo-69-12888-g004.jpg

相似文献

1
[An integrated approach to the treatment of pretibial myxedema based on pulse therapy with prednisolone and electrical neuromyostimulation (FREMS-therapy) in a patient with Graves' disease and thyroid eye disease].[基于泼尼松龙脉冲疗法和电神经肌肉刺激(FREMS疗法)对一名患有格雷夫斯病和甲状腺眼病患者的胫前黏液性水肿进行综合治疗]
Probl Endokrinol (Mosk). 2023 Aug 30;69(4):32-37. doi: 10.14341/probl12888.
2
Triad of exophthalmos, pretibial myxedema, and acropachy in a patient with Graves' disease.一名格雷夫斯病患者出现突眼、胫前黏液性水肿和杵状指三联征。
J Am Acad Dermatol. 2003 Jun;48(6):970-2. doi: 10.1067/mjd.2003.323.
3
Orbital decompression in Graves' ophthalmopathy associated with pretibial myxedema.格雷夫斯眼病合并胫前黏液性水肿的眼眶减压术
J Endocrinol Invest. 1993 Jun;16(6):433-7. doi: 10.1007/BF03348875.
4
Pretibial myxedema as the initial manifestation of Graves' disease.胫前黏液性水肿作为格雷夫斯病的初始表现。
J Eur Acad Dermatol Venereol. 2002 Jul;16(4):380-3. doi: 10.1046/j.1468-3083.2002.00567.x.
5
Concurrent pretibial myxedema and thyroid eye disease following mRNA COVID-19 vaccine in a patient with history of Graves' disease.mRNA COVID-19 疫苗接种后伴 Graves 病病史患者出现胫前黏液水肿和甲状腺眼病。
Ann Endocrinol (Paris). 2024 Apr;85(2):100-103. doi: 10.1016/j.ando.2023.10.004. Epub 2023 Oct 20.
6
Pretibial myxedema and high-dose intravenous immunoglobulin treatment.胫前黏液性水肿与大剂量静脉注射免疫球蛋白治疗
Thyroid. 1994 Winter;4(4):399-408. doi: 10.1089/thy.1994.4.399.
7
[Treatment of Graves' disease in patients with thyroid eye disease].[甲状腺眼病患者的格雷夫斯病治疗]
Vestn Oftalmol. 2021;137(6):128-135. doi: 10.17116/oftalma2021137061128.
8
Graves' disease with pretibial myxedema.格雷夫斯病伴胫前黏液性水肿。
Arch Dermatol. 1969 Jan;99(1):117-9. doi: 10.1001/archderm.99.1.117.
9
Octreotide and Graves' ophthalmopathy and pretibial myxoedema.奥曲肽与格雷夫斯眼病和胫前黏液性水肿
BMJ. 1992 Jan 18;304(6820):158. doi: 10.1136/bmj.304.6820.158.
10
Lower extremity manifestations of Graves' disease.格雷夫斯病的下肢表现。
J Foot Ankle Surg. 1995 Sep-Oct;34(5):489-97. doi: 10.1016/S1067-2516(09)80026-4.

本文引用的文献

1
A case of pretibial myxedema treated with teprotumumab.1例用替普罗单抗治疗的胫前黏液性水肿病例。
JAAD Case Rep. 2021 Sep 1;16:134-136. doi: 10.1016/j.jdcr.2021.08.026. eCollection 2021 Oct.
2
Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease.用替普罗单抗治疗格雷夫斯病患者的胫前黏液性水肿消退情况。
JAAD Case Rep. 2020 Sep 15;6(12):1281-1282. doi: 10.1016/j.jdcr.2020.09.003. eCollection 2020 Dec.
3
Severe pretibial myxedema refractory to systemic immunosuppressants.对全身免疫抑制剂难治的重度胫前黏液性水肿。
Cutis. 2019 Sep;104(3):E1-E3.
4
Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review.复杂甲状腺眼病治疗体系中的眼眶减压:病例报告与文献综述
Int Med Case Rep J. 2018 Oct 1;11:243-249. doi: 10.2147/IMCRJ.S164372. eCollection 2018.
5
The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy.2016年欧洲甲状腺协会/欧洲Graves眼病研究组Graves眼病管理指南
Eur Thyroid J. 2016 Mar;5(1):9-26. doi: 10.1159/000443828. Epub 2016 Mar 2.
6
Successful Treatment of Dercum's Disease by Transcutaneous Electrical Stimulation: A Case Report.经皮电刺激成功治疗德卡姆病:一例报告
Medicine (Baltimore). 2015 Jun;94(24):e950. doi: 10.1097/MD.0000000000000950.
7
Improvement in clinical symptoms of scleredema diabeticorum by frequency-modulated electromagnetic neural stimulation: a case report.调频电磁神经刺激改善糖尿病性硬皮病临床症状:一例报告
Diabetes Care. 2014 Nov;37(11):e233-4. doi: 10.2337/dc14-0730.
8
Extrathyroidal manifestations of Graves' disease: a 2014 update.格雷夫斯病的甲状腺外表现:2014年更新
J Endocrinol Invest. 2014 Aug;37(8):691-700. doi: 10.1007/s40618-014-0097-2. Epub 2014 Jun 10.
9
A new approach to rheumatoid arthritis: treating inflammation with computerized nerve stimulation.类风湿性关节炎的一种新方法:用计算机化神经刺激治疗炎症。
Cerebrum. 2012 Mar;2012:3. Epub 2012 Mar 21.
10
Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial.调频电磁神经刺激(FREMS)治疗有症状的糖尿病周围神经病变:一项双盲、随机、多中心、长期、安慰剂对照临床试验的结果。
Diabetologia. 2013 Mar;56(3):467-75. doi: 10.1007/s00125-012-2795-7. Epub 2012 Dec 13.